PODD vs PROF · P/E 34, rev $2.07B vs rev $10.7M
Insulet Corporation (PODD) versus Profound Medical Corp (PROF) — a side-by-side from cached financials, not a winner call.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
PODD currently screens at market cap $9.94B and trailing P/E 33.5. PROF currently screens at market cap $238.7M.
Not investment advice. Open the PODD and PROF stock pages for the full models.
Not investment advice.